Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Jul 30, 2014

Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement

No Customer or Revenue Impact Expected
Jul 29, 2014

Cepheid Reports China Installed Base Close To 1,000 GeneXpert® Systems

Program to Enable Broader Access to Groundbreaking Tuberculosis Diagnostic
Jul 17, 2014

Cepheid Reports 2014 Second Quarter Results

Record HBDC Placements and Strength in North America Reagents Drive 27% Clinical Growth
Jul 3, 2014

Cepheid Schedules 2014 Second Quarter Results Announcement And Webcast
Jun 19, 2014

Cepheid And Leading Pharmaceutical Companies Partner On A Diagnostic Test To Help Tackle Multidrug-Resistant Bacterial Infections

Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK
Jun 16, 2014

Cepheid Announces European Release of Xpert Carba-R, a Molecular Test for Rapid and Accurate Detection of Carbapenemase-producing Gram-negative Bacteria

On-demand molecular test detects and differentiates the genes encoding the most prevalent carbapenemases: KPC, NDM, VIM, OXA-48 and IMP-1
Jun 9, 2014

Cepheid Welcomes Executive Vice President Of International Commercial Operations
May 22, 2014

Cepheid to Webcast Upcoming Financial Presentations
Apr 29, 2014

Cepheid to Webcast Upcoming Financial Presentations
Apr 17, 2014

Cepheid Reports 2014 First Quarter Results

Strong Commercial and HBDC Drive Clinical Growth of 26%

Show per page

Back to Top